US Edition
Nipah monoclonal antibody trials may begin in India in 2025
Summary by sciencechronicle.in
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Nipah monoclonal antibody trials may begin in India in 2025
If the Indian drug regulator greenlights it, a human clinical trial to test the safety and efficacy of a novel Nipah monoclonal antibody MBP1F5, which might offer immediate protection to people at risk of infection against the deadly disease, might begin next year. A similar trial will be carried out in Bangladesh as well. Though … Continue reading Nipah monoclonal antibody trials may begin in India in 2025
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
